Amyotrophic Lateral Sclerosis (ALS) Families Project

ConditionALS
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-105
SponsorColumbia University

About this trial

This program provides family members of individuals with familial ALS the opportunity to contribute to research focused on learning more about why motor neuron degeneration begins and how or why it progresses. This study provides genetic counseling and testing to help participants understand and manage their risk and determine if they want to learn their genetic status. This study will follow unaffected ALS gene mutation carriers on an annual basis to gather essential information that will ultimately help researchers develop novel therapies for the prevention and treatment of ALS.

Eligibility criteria

Qualifiers

Men or women of any race or ethnicity aged 18 or older

No symptoms of ALS or fronto-temporal dementia at enrollment

Scenario 1: has already had genetic testing that identified an ALS-spectrum gene mutation.

Scenario 2: has a first degree relative who was/is an obligate carrier of a familial ALS-spectrum gene mutation.

Disqualifiers

Known HIV

Known hepatitis B

Known hepatitis C

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Columbia University10032, New YorkNew York, United States

Sponsors and collaborators

Columbia University

Lead sponsor